A Comparison of Symbicort® Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The primary objective is to compare the efficacy of Symbicort Single inhaler Therapy with
treatment according to conventional best practice in adult patients with persistent asthma.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Budesonide, Formoterol Fumarate Drug Combination Formoterol Fumarate Salmeterol Xinafoate